Big Pharma’s Billion-Dollar Weight Loss Drug Market

The introduction of weight management and obesity-targeting drugs has induced excitement from Wall Street to Main Street. This enthusiasm is rooted in the pressing global health concern of obesity and its associated conditions, such as cardiovascular diseases, diabetes, and certain cancers.